NANOPORTAL
LIVE

Serial Number

97382032

Owner

Vivani Medical, Inc.

Attorney

Scott B. Dunbar

Filing Date

Apr 26, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NANOPORTAL Trademark

Serial Number: 97382032

NANOPORTAL is a trademark filed by Vivani Medical, Inc. on April 26, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Vivani Medical, Inc.

1350 S. Loop Road
Alameda, CA 94502

Entity Type: 03

Trademark Details

Filing Date

April 26, 2022

Registration Date

Not Registered

Goods & Services

Implantable drug delivery devices injected through a small needle having a drug reservoir and a nanoporous membrane; miniature long-term drug implants utilizing proprietary implantable drug delivery technology

Implantable drug delivery devices injected through a small needle having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic diseases namely, metabolic diseases being diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathy

International Class 001: Nanoporous membranes in chemical form used in drug delivery devices injected through a small needle for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; nanoporous membranes in chemical form used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant; nanoporous membranes in chemical form used in drug delivery devices injected through a small needle for improving medication adherence in the treatment of chronic diseases, namely, metabolic diseases being diabetes, obesity or non- alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathy; nanoporous membranes in chemical form used for improving medication adherence in the treatment of chronic diseases namely, metabolic diseases being diabetes, ยท obesity or non-alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases being diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathy

Filing History

ASSIGNED TO EXAMINER
May 11, 2026 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 30, 2026 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 3, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 3, 2025 GNSL
SUSPENSION LETTER WRITTEN
Sep 3, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2025 TROA
NOTICE OF REVIVAL - E-MAILED
Jul 25, 2025 NREV
PETITION TO REVIVE-GRANTED
Jul 25, 2025 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 25, 2025 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 22, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 22, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 7, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 7, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 7, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 24, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2024 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 27, 2024 RCCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 5, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 5, 2024 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 30, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 14, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 30, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
May 30, 2023 GNSL
SUSPENSION LETTER WRITTEN
May 30, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 15, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 15, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 15, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 13, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 2, 2022 NWOS
NEW APPLICATION ENTERED
Apr 29, 2022 NWAP